Navinci Diagnostics AB

https://www.navinci.se

Navinci (formerly known as Olink Bioscience) is a Swedish life science company that develops and markets in situ proximity ligation assays to detect proteins, their interactions, and modifications in tissue and cell samples, with initial focus on immuno-oncology research and drug development. The technology provides an essential tool for studying spatial biology with high specificity and directly reveal responses to disease and drug treatment in tissue microenvironments. *

	Start	2022-07-12 renamed before
	Predecessor	Olink Bioscience AB (Olink Proteomics)
	Industry	PLA technology (Proximity Ligation Assay technology)
	Person	Gunnarsson, Robert (Navinci Diagnostics 2020– CEO)
	Person 2	Landegren, Ulf

	Region	Uppsala
	Country	Sweden
	Street	3 Husargatan Biomedical Centre (BMC), Entrance C11, Uppsala University
	City	75124 Uppsala
		Address record changed: 2022-07-18

Basic data	Employees	n. a.

		* Document for »About Section«: Navinci Diagnostics AB. (7/12/22). "Press Release: Navinci Diagnostics AB Announces Closing of SEK 90M Series A Financing, Led by Segulah Medical Acceleration with Support from Existing Shareholders".

		Record changed: 2024-02-12

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Navinci Diagnostics AB

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)